News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

At first glance, a room in the basement of McGill Hall on the University of Montana campus appears like a private gym with treadmills, dumbbells and exercise bikes.  It seems like a good place for a workout. But the space is actually a research laboratory for students and faculty in UM’s School of Integrative Physiology and Athletic Training within the College of Health. 

University of Montana
|
March 20, 2024

Doug Brinkerhoff intends to use computer deep learning to improve predictions of sea level rise from melting ice sheets. Beverly Piggott will study how brain cells regulate their own acidity during development.

A team of scientists from Montana State University recently published unique research examining how individual cells respond to viral infection. The work used state-of-the-art technology to culture cells and track infection in real time; it is the first known project to use microfluidic technology to culture, infect and track infection on a single-cell level. 

A Montana State University researcher was recently awarded a $2.76 million, five-year grant from the National Institutes of Health to help find pre-symptom evidence of the onset of osteoarthritis, a disease that affects one in seven Americans. 

Wintermute Biomedical has successfully raised USD 1.3 million from investors to propel its groundbreaking Shingles treatment, Solexan™, into a Phase Ib clinical trial. The primary focus of this randomized double-blind placebo-controlled trial is to assess the safety, tolerability, and proof-of-concept efficacy of Solexan™ in reducing shingles-related pain and expediting lesion healing.

ARTICLES OF INTEREST

Bio.News
|
May 22, 2023

Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food and Drug Administration (FDA) announced it has approved Arexvy, the first-ever RSV vaccine for individuals 60 and over.

National Institutes of Health
|
May 5, 2023

Information on Small Business Funding Webinar, National Small Business Week, America’s SEED Fund Week — and more

National Institutes of Health
|
March 27, 2023

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]

FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.

Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology  that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.

NEWSLETTER

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!

Newsletter
|
December 21, 2023

View the Winter 2023 Newsletter now!